Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.
Driouich JS, Cochin M, Lingas G, Luciani L, Baronti C, Bernadin O, Gilles M, Villarroel PMS, Moureau G, Petit PR, Dupont A, Izopet J, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Nguyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Tine J, Basilua JM, Angoulvant D, Tardivon C, Blancho G, Martin-Blondel G, Yazdanpanah Y, Mentré F, Lévy V, Touret F, Guedj J, de Lamballerie X, Nougairède A. Driouich JS, et al. Among authors: gottenberg je. Biomed Pharmacother. 2024 Aug;177:116988. doi: 10.1016/j.biopha.2024.116988. Epub 2024 Jun 18. Biomed Pharmacother. 2024. PMID: 38897157 Free article.
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg.
Touret F, Martin-Blondel G, de Lamballerie X, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, N'Guyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Barthélémy K, Priet S, Nurtop E, Sanchez VP, Tardivon C, Blancho G, Le Bourgeois A, Lévy V. Touret F, et al. Among authors: gottenberg je. J Infect. 2023 May;86(5):e126-e129. doi: 10.1016/j.jinf.2023.02.002. Epub 2023 Feb 5. J Infect. 2023. PMID: 36750165 No abstract available.
Non-primary Sjogren's Syndrome: Secondary or associated?
Felten R, Meyer A, Gottenberg JE. Felten R, et al. Among authors: gottenberg je. Joint Bone Spine. 2023 Mar;90(2):105502. doi: 10.1016/j.jbspin.2022.105502. Epub 2022 Dec 1. Joint Bone Spine. 2023. PMID: 36464213 No abstract available.
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force. Seror R, et al. Among authors: gottenberg je. Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5. Ann Rheum Dis. 2016. PMID: 25480887
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.
Spinner CD, Bell S, Einsele H, Tremblay C, Goldman M, Chagla Z, Finckh A, Edwards CJ, Aurer I, Launay O, Casañas I Comabella C, James S, Dube S, Borkowska K, Jah F, Kandeil W, Yokota RTC, Artaud C, Gottenberg JE, Gesualdo L, Bertrand D, Arnetorp S, Magiorkinis G. Spinner CD, et al. Among authors: gottenberg je. Adv Ther. 2024 Dec 16. doi: 10.1007/s12325-024-03043-0. Online ahead of print. Adv Ther. 2024. PMID: 39680311 Review.
Stability of symptom-based subtypes in Sjogren's disease.
Berry JS, Tarn J, Casement J, Lendrem D, Thompson K, Mariette X, Gottenberg JE, Ng WF. Berry JS, et al. Among authors: gottenberg je. RMD Open. 2024 Nov 24;10(4):e004914. doi: 10.1136/rmdopen-2024-004914. RMD Open. 2024. PMID: 39581689 Free PMC article.
French protocol for the diagnosis and management of giant cell arteritis.
de Boysson H, Devauchelle-Pensec V, Agard C, André M, Bienvenu B, Bonnotte B, Carvajal Alegria G, Espitia O, Hachulla E, Heron E, Lambert M, Lega JC, Ly KH, Mekinian A, Morel J, Regent A, Richez C, Sailler L, Seror R, Tournadre A, Samson M; Collaborators. de Boysson H, et al. Rev Med Interne. 2024 Oct 31:S0248-8663(24)00810-5. doi: 10.1016/j.revmed.2024.10.011. Online ahead of print. Rev Med Interne. 2024. PMID: 39487062 Free article. Review.
Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trial.
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, Salliot C, Poiroux L, Nguyen M, Roux CH, Richez C, Saraux A, Vergne-Salle P, Morel J, Flipo RM, Piperno M, Gottenberg JE, Marotte H, Soubrier M, Gossec L, Dieudé P, Lassoued S, Zabraniecki L, Couture G, Boyer JF, Jamard B, Degboe Y, Constantin A. Ruyssen-Witrand A, et al. Among authors: gottenberg je. Ann Rheum Dis. 2024 Oct 29:ard-2024-226620. doi: 10.1136/ard-2024-226620. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39472058 Free article.
341 results